GSK1940029, also known as SCD Inhibitor 1, is a SCD Inhibitor. GSK1940029 is a potential topical treatment of acne.
For research use only. We do not sell to patients.
Name | GSK1940029 |
---|---|
Iupac Chemical Name | 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyltriazole-4-carboxamide |
Synonyms | GSK1940029; GSK-1940029; GSK 1940029; SCD Inhibitor 1; |
Molecular Formula | C18H16Cl2N4O2 |
Molecular Weight | 391.252 |
Smile | O=C(C1=C(C)N(CC2=CC=C(Cl)C(Cl)=C2)N=N1)NC3=CC=C(CO)C=C3 |
InChiKey | QQRGSFYTPBYCFD-UHFFFAOYSA-N |
InChi | InChI=1S/C18H16Cl2N4O2/c1-11-17(18(26)21-14-5-2-12(10-25)3-6-14)22-23-24(11)9-13-4-7-15(19)16(20)8-13/h2-8,25H,9-10H2,1H3,(H,21,26) |
CAS Number | 1150701-66-8 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid to white solid |
---|---|
Purity | >98% |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |